Bitget App
Trading lebih cerdas
Beli kriptoPasarTradingFuturesEarnWawasanSelengkapnya
Harga
Data
Tentang
BMY stock price forecast
Berita
Kompetitor
Tokenisasi
Kripto
FAQ
Logo saham Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

BMY·NYSE

Terakhir diperbarui pada 2026-02-13 10:17 EST. Informasi harga saham bersumber dari TradingView dan merefleksikan harga pasar real time.

Insight
Kalkulator
Berita

Perubahan harga saham BMY

Pada hari perdagangan terakhir, saham BMY ditutup pada harga 60.91 USD, dengan perubahan harga sebesar 1.64% untuk hari tersebut.
Perdagangan futures saham

Tentang Bitget

Exchange Universal (UEX) pertama di dunia, yang memungkinkan pengguna untuk trading tidak hanya mata uang kripto, tetapi juga saham, ETF, forex, emas, dan aset dunia nyata (RWA).
Pelajari selengkapnya

Data utama BMY

Penutupan sebelumnya60.91 USD
Kap. pasar124.01B USD
Volume2.27M
Rasio P/E17.61
Imbal hasil deviden (12 Bulan Terakhir)4.15%
Jumlah dividen0.63 USD
Tanggal tanpa dividen terakhirJan 02, 2026
Tanggal pembayaran terakhirFeb 02, 2026
EPS terdilusi (12 Bulan Terakhir)3.46 USD
Pendapatan bersih (Tahun Fiskal)7.05B USD
Pendapatan (Tahun Fiskal)48.19B USD
Tanggal laporan berikutnyaApr 30, 2026
Estimasi EPS1.440 USD
Estimasi pendapatan10.81B USD USD
Saham beredar2.03B
Beta (1T)0.38
Tokenized stocks

Apakah kamu pernah mendengar tentang saham yang ditokenisasi?

Cara baru untuk trading saham — kapan saja, di mana saja, 24/7.

Pelajari selengkapnya

Ringkasan Bristol-Myers Squibb Company

Bristol Myers Squibb Co. bergerak dalam penemuan, pengembangan, lisensi, manufaktur, pemasaran, distribusi, dan penjualan produk biofarmasi. Perusahaan ini menawarkan molekul kecil, produk yang dihasilkan dari proses biologis yang disebut biologik, serta terapi sel reseptor antigen chimeric (CAR-T). Perusahaan ini didirikan pada Agustus 1933 dan berkantor pusat di Princeton, NJ.
Sektor
Teknologi kesehatan
Industri
Farmasi: Perusahaan Besar
CEO
Christopher S. Boerner
Kantor Pusat
Princeton
Situs web
bms.com
Didirikan
1933
Karyawan (Tahun Fiskal)
-
Perubahan (1T)
-
Pendapatan / Karyawan (1T)
-
Pendapatan bersih / karyawan (1T)
-

BMY Pulse

Daily updates on BMY stock prices, fund flows, and market news, generated by AI and reviewed by our team of analysts. Always DYOR.

• Perubahan harga saham BMY dalam 24 jam: -1,53%. Dari 60,86 USD menjadi 59,93 USD (per 11 Februari 2026). Penurunan tipis ini terjadi setelah reli pasca-laporan pendapatan, saat investor menyeimbangkan pertumbuhan pendapatan Q4 yang kuat ($12,5 miliar) dengan panduan laba FY2026 yang hati-hati, yang tidak memenuhi ekspektasi beberapa analis akibat penurunan produk warisan.
• Dari perspektif teknikal, BMY menunjukkan "momentum bullish menghadapi resistensi overbought": saham telah melonjak lebih dari 30% dalam tiga bulan, diperdagangkan jauh di atas rata-rata pergerakan 50-hari ($54,82) dan 200-hari ($49,20). Namun, RSI (Relative Strength Index) mendekati 70 mengindikasikan kondisi overbought jangka pendek, menandakan potensi konsolidasi sehat atau koreksi minor setelah harga tertinggi 52-minggu terbaru di $63,33.
• Bristol Myers Squibb melaporkan pendapatan Q4 2025 pada 5 Februari, melampaui estimasi pendapatan ($12,5 miliar vs $12,2 miliar) berkat lonjakan 15% dalam portofolio pertumbuhan, meskipun EPS sebesar $1,26 tidak memenuhi konsensus $1,65 akibat biaya R&D.
• BMY menetapkan panduan pendapatan FY2026 antara $46 miliar dan $47,5 miliar, melebihi estimasi konsensus dan menunjukkan kepercayaan pada peluncuran obat baru yang mengimbangi penurunan paten produk warisan seperti Revlimid.
• Perusahaan meningkatkan dividen kuartalan menjadi $0,63 per saham, mewakili imbal hasil tahunan sebesar 4,1%, memperkuat statusnya sebagai saham pendapatan utama bagi investor defensif.
• FDA mengumumkan niat untuk membatasi bahan aktif GLP-1 yang tidak disetujui pada 6 Februari, sebuah langkah untuk melindungi pasar farmasi dari alternatif komposisi yang belum diverifikasi.
• Raksasa farmasi seperti Eli Lilly dan BridgeBio melaporkan investasi manufaktur signifikan dan hasil positif uji klinis Fase 3 minggu ini, menandakan siklus inovasi yang kuat di sektor bioteknologi pada awal 2026.
Lihat lebih banyak
Sekitar 23j yang lalu
• Perubahan harga saham BMY dalam 24 jam: -0,28%. Dari 60,77 USD menjadi 60,60 USD.
• Dari perspektif teknikal, BMY menunjukkan "momentum bullish dengan konsolidasi jangka pendek": tren jangka panjang positif dengan harga tetap di atas rata-rata pergerakan 50-hari dan 200-hari (SMA), meskipun indikator jangka pendek seperti RSI (59,5) dan Stochastics mengindikasikan saham mendekati area overbought setelah lonjakan mingguan 8,7% baru-baru ini. Dukungan utama berada di $56,49, sementara resistensi berada di sekitar $62,05.
• Bristol Myers Squibb melaporkan laba Q4 2025 sebesar $1,26 EPS, di bawah estimasi karena biaya akuisisi, namun memberikan panduan optimis untuk 2026 yang melebihi ekspektasi pasar, dengan pertumbuhan portofolio imunoonkologi sebagai alasan utama.
• Perusahaan meluncurkan kampanye "Change the Target" bersama Johnson & Johnson untuk memenuhi kebutuhan yang belum terpenuhi dalam perawatan kardiovaskular, secara khusus menargetkan faktor XIa guna mengurangi risiko stroke tanpa meningkatkan risiko perdarahan.
• BMY mengumumkan kenaikan dividen tahunan ke-17 berturut-turut menjadi $0,63 per saham, menyoroti arus kas yang kuat dan komitmen terhadap pengembalian kepada pemegang saham meskipun ada tekanan "patent cliff" pada obat-obatan lama.
• Industri farmasi AS menghadapi perubahan besar seiring pemerintah mengumumkan 15 obat mahal berikutnya untuk negosiasi harga di bawah Inflation Reduction Act, termasuk blockbuster dari Gilead dan Eli Lilly.
• Kebijakan perdagangan baru membentuk ulang sektor ini, dengan AS mengusulkan tarif khusus farmasi hingga 150% pada tahun 2026, mendorong perusahaan besar seperti Eli Lilly untuk mengumumkan investasi manufaktur domestik sebesar $27 miliar.
Lihat lebih banyak
Sekitar 1H yang lalu

BMY stock price forecast

Berdasarkan indikator teknis untuk saham BMY, harga diperkirakan akan berfluktuasi di kisaran 72.25–83.39 USD selama seminggu ke depan. Analis pasar memprediksi bahwa harga saham BMY kemungkinan akan berfluktuasi di kisaran 65.11–85.62 USD selama beberapa bulan ke depan.

Based on 1-year price forecasts from 53 analysts, the highest estimate is 122.19 USD, while the lowest estimate is 69.82 USD.

For more information, please see the BMY stock price forecast Stock Price Forecast page.

Latest BMY stock news

Hanya dengan akun Bitget, kamu dapat trading saham dan mata uang kripto secara bersamaan.

Gabung Sekarang!

FAQ

Berapa harga saham Bristol-Myers Squibb Company?

BMY saat ini diperdagangkan pada harga 60.91 USD — harganya telah berubah sebesar 1.64% dalam 24 jam terakhir. Kamu dapat memantau kinerja harga saham Bristol-Myers Squibb Company secara lebih detail pada grafik harga di bagian atas halaman ini.

Apa ticker saham dari Bristol-Myers Squibb Company?

Tergantung pada exchange, ticker saham dapat bervariasi. Misalnya, di NYSE, Bristol-Myers Squibb Company diperdagangkan dengan ticker saham BMY.

Berapa prakiraan harga saham BMY?

Kami telah mengumpulkan pendapat para analis mengenai harga Bristol-Myers Squibb Company dimasa depan. Menurut prakiraan mereka, BMY memiliki estimasi maksimum 609.15 USD dan estimasi minimum 121.83 USD.

Berapa kapitalisasi pasar Bristol-Myers Squibb Company?

Bristol-Myers Squibb Company memiliki kapitalisasi pasar sebesar 124.01B USD.

What is P/E ratio (TTM)?

The P/E ratio (TTM) stands for price-to-earnings ratio (trailing twelve months). It is a historical valuation metric calculated using a company's earnings per share (EPS) over the most recent twelve consecutive months, reflecting the company's past profitability.

The P/E ratio measures the relationship between a stock's price and a company's profitability, and is often used as a basis for judging whether a stock is "cheap" or "expensive."

P/E ratio = market price (P) ÷ earnings per share (EPS), or P/E ratio = total market capitalization ÷ net profit attributable to shareholders

The interpretation of the P/E ratio (TTM) should always be considered alongside other factors and is mainly used for valuation comparisons rather than as a standalone indicator.

  • A lower P/E ratio (TTM) means investors are paying less for each unit of earnings. This may indicate that the stock is undervalued, or that the market has limited expectations for the company's future growth, such as in mature or slow-growing industries.
  • A higher P/E ratio (TTM) means investors are paying more for each unit of earnings. This often reflects expectations of strong future earnings growth, which is common among growth or technology stocks, though it may also suggest the stock is overvalued.
  • Comparison with peers: Compare the company's P/E (TTM) with the average or median P/E of other companies in the same industry. A significantly higher P/E may require further analysis to determine whether the company's high valuation is justified by stronger growth prospects or competitive advantages.
  • Comparison with historical levels: Compare the company's current P/E (TTM) with its own historical average (such as over the past 5 or 10 years) to assess whether the current valuation is at a historical high or low.
  • Comparison with the broader market: Compare the company's P/E (TTM) with major market indices (such as the S&P 500) to see how the market is valuing the company overall.

P/E ratios can vary widely across industries, and there is no single "ideal" P/E level. A reasonable P/E range depends on the industry, the company's growth potential, and the broader macroeconomic environment. Investment decisions should not rely solely on the P/E ratio (TTM) but should be based on a comprehensive analysis that includes company quality, growth prospects, and financial health.

Can I trade stocks on Bitget?

You can trade stocks on Bitget, but mainly through stock tokens and stock perps, rather than by directly buying or selling traditional stocks.

This approach reflects Bitget's vision as a Universal Exchange (UEX), designed to connect traditional financial markets with cryptocurrency markets.

Bitget currently offers the following stock-related trading formats:

1. Stock tokens (spot)

Nature: Stock tokens are digital tokens pegged to the price of specific traditional stocks (such as TSLAUSDT and NVDAUSDT) and are traded on Bitget's spot market.

Features: When you trade stock tokens, you are buying and holding tokens rather than owning the underlying traditional stocks.

  • The price of these tokens generally follows the price movements of the stocks they are pegged to, such as Tesla or Nvidia.
  • The advantage is that you can participate in the price movements of traditional financial assets, such as U.S. stocks, using cryptocurrencies (for example, USDT), without the need for a traditional brokerage account.

2. Stock perps

Nature: Bitget also offers USDT-margined perpetual futures, commonly referred to as stock perps, based on major U.S. blue-chip stocks such as Tesla and Meta.

Characteristics: Stock perps are derivative products that allow you to take a bullish or bearish view on the future price of an underlying stock through margin trading. These products typically support leverage, such as up to 25x.

It does not involve owning the underlying stock. Instead, profits and losses are settled based on price movements of the futures.

Important note: When trading stock perps on Bitget, you are participating in derivative markets within the cryptocurrency ecosystem. This is fundamentally different from purchasing publicly traded shares through a traditional brokerage, as you do not own equity in the underlying company.

Futures trading and the use of leverage involve high risk. Please ensure you fully understand the risks before trading.

If you wish to directly hold equity in traditional stocks and enjoy shareholder rights (such as receiving dividends), you must trade through a regulated traditional securities brokerage or brokerage platform.

What are the advantages of Bitget's stock perps?

Bitget's stock perps—typically perpetual futures based on stock tokens prices—are an innovative offering that allows cryptocurrency platforms to provide exposure to traditional financial markets.

Compared to traditional stock or futures trading, they offer several unique advantages, primarily due to the platform's trading infrastructure.

Bitget's stock perps, typically USDT-denominated derivatives, offer the following key advantages:

1. Trading convenience and global accessibility

  • 24/7 trading: Traditional stock markets, such as U.S. equity markets, operate during fixed trading hours. In contrast, cryptocurrency derivatives markets are typically open 24/7. This means investors can trade anytime, capitalizing on breaking news or market fluctuations.
  • Lower entry barriers and faster onboarding: Compared with traditional brokerages, which often require extensive identity verification and lengthy account setup processes, Bitget generally offers faster account onboarding. Users can trade using cryptocurrencies such as USDT, without the need for complex fiat deposit and withdrawal procedures.
  • Global accessibility: Users can access derivatives trading linked to globally recognized stocks via the Bitget platform, subject to applicable regulations.

2. Capital efficiency and high leverage

  • High leverage options: Stock perps typically offer higher leverage than traditional stock trading (for example, up to 25x). This allows traders to control larger positions with smaller margin requirements, improving capital efficiency.
    Note: While high leverage can amplify gains, it also amplifies losses proportionally.
  • Two-way trading: Traders can easily take both long and short positions. This means traders can potentially profit from market volatility whether stock prices rise or fall, provided the market direction is correctly anticipated.

3. Trading and settlement using cryptocurrency

  • USDT margin: Stock perps on Bitget typically use USDT (or other stablecoins) as the margin and settlement currency. For users who already hold cryptocurrency, there is no need to convert assets into fiat currency, allowing them to trade directly with stablecoins.
  • Efficient fund transfers: Crypto-based transfers and settlements are typically faster than traditional fiat systems, enabling more efficient global fund allocation.

4. Integration

One-stop platform: Bitget allows users to trade spot cryptocurrencies, crypto derivatives, and stock perps on a single platform, making it easier to manage different asset types in one place.

Peringatan risiko:

While Bitget's stock perps offer several advantages, it is important to understand the associated risks.

  • High leverage risk: Leveraged trading can result in rapid loss of your entire margin.
  • No equity ownership: When trading stock perps, you do not own the underlying shares. As a result, you are not entitled to dividends or voting rights.
  • Market liquidity risk: Tokenized stock perps may have lower liquidity than their counterparts in traditional stock markets, especially outside regular trading hours.

In summary, Bitget's stock perps offer advantages such as greater trading flexibility, lower entry barriers, and higher capital efficiency.

What are the trading fees for Bitget stock perps?

Trading fees for Bitget stock perps (USDT-margined perpetual futures) mainly include transaction fees and funding rates.

Transaction fees:

Bitget offers limited-time fee promotions for stock perps (especially tokenized stock perps) from time to time to attract traders.

Standard reference rates: Under Bitget's standard futures fee structure, the taker fee is typically around 0.06%, while the maker fee is around 0.02%.

Current promotions for stock perps (important): To promote its stock perps products, Bitget is offering discounted transaction fees during Q4 2025, with taker fees as low as 0.006% and maker fees as low as 0.002%. There is also a limited-time promotion offering zero-fee trading for spot stock tokens.

Rekomendasi: Karena kegiatan promosi dapat berubah atau berakhir kapan saja, silakan kunjungi halaman resmi “ Fee overview ” atau “ Announcement Center ” Bitget untuk mendapatkan tarif terbaru dan paling akurat pada saat melakukan perdagangan.

Funding rate:

The funding rate is a key mechanism in perpetual futures (including stock perps) that helps keep the futures price closely aligned with the spot price of the underlying asset. It is not a fee charged by the platform, but a periodic payment exchanged between long and short traders.

Funding rates fluctuate dynamically and are mainly driven by market sentiment and imbalances between long and short positions. Stock perps generally experience lower volatility than cryptocurrencies, so funding rates are often relatively low during stable market conditions. However, during earnings seasons or major positive or negative news events, heavy concentration of long or short positions—such as in high-growth technology stocks like Tesla or Nvidia—can create significant imbalances, causing funding rates to spike in the short term.

Funding payments are typically settled every 8 hours. If you close your position before the funding settlement time, no funding payment will be charged or received.

Funding rates are not fixed. If you hold a position for an extended period, high positive funding rates (for long positions) or high negative funding rates (for short positions) will affect your overall holding costs or potential returns. For this reason, it is important to monitor the funding rate in real time on the trading interface.

NYSE/
BMY